Novavax Inc (NASDAQ:NVAX)

9.15
Delayed Data
As of Feb 27
 -0.16 / -1.72%
Today’s Change
3.34
Today|||52-Week Range
9.83
+54.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues343.0K14.7M22.1M20.9M
 
 
 
 
 
Cost of Goods Sold--5.4M13.0M5.6M
 
 
 
 
Depreciation And Amortization1.4M1.6M1.7M2.6M
 
 
 
 
 
 
Operating ExpensesGross Income--7.7M7.4M12.7M
 
 
 
 
General Expenses--29.3M37.0M63.8M
 
 
 
 
Research And Development28.0M17.9M26.1M50.3M
 
 
 
 
 
Total Operating Expenses38.8M36.3M51.7M72.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-38.5M-21.6M-29.7M-51.1M
 
 
 
 
 
Extraordinary Credit1.7M2.5M101.0K267.0K
 
 
 
 
 
Extraordinary Charge0.000.000.00-1.3M
 
 
Interest Expense On Debt9.0K9.0K32.0K160.0K
 
 
 
 
 
Other Expenses--26.0K924.0K182.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-36.2M-19.0M-28.5M-52.0M
 
 
 
 
 
Income Taxes-450.0K-412.0K0.00-25.0K
 
 
 
 
Net Income-35.7M-19.4M-28.5M-52.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS104.8M113.6M131.7M169.7M
 
 
 
 
 
Shares To Calculate EPS Diluted104.8M113.6M131.7M169.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.34-$0.17-$0.22-$0.31
 
 
 
 
 
EPS Diluted-$0.34-$0.17-$0.22-$0.31
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account